Safety and efficacy results from TRANSCEND NHL 001, a multicenter phase 1 study of lisocabtagene maraleucel (liso-cel) in relapsed/refractory large B-cell lymphoma Meeting Abstract


Authors: Abramson, J.; Palomba, M. L.; Gordon, L.; Lunning, M.; Wang, M.; Arnason, J.; Mehta, A.; Purev, E.; Maloney, D.; Andreadis, C.; Sehgal, A.; Solomon, S.; Ghosh, N.; Albertson, T.; Garcia, J.; Kostic, A.; Li, D.; Kim, Y.; Siddiqi, T.
Abstract Title: Safety and efficacy results from TRANSCEND NHL 001, a multicenter phase 1 study of lisocabtagene maraleucel (liso-cel) in relapsed/refractory large B-cell lymphoma
Meeting Title: 60th Annual Scientific Meeting of the British Society for Haematology (BSH)
Journal Title: British Journal of Haematology
Volume: 189
Issue: Suppl. 1
Meeting Dates: 2020 Apr 27-29
Meeting Location: Birmingham, UK
ISSN: 0007-1048
Publisher: John Wiley & Sons  
Date Published: 2020-04-01
Start Page: 94
End Page: 95
Language: English
ACCESSION: WOS:000528597400130
PROVIDER: wos
PUBMED: 32337705
DOI: 10.1111/bjh.16638
Notes: Meeting cancelled due to COVID-19 pandemic -- Meeting Abstract: BSH2020-PO-082 -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Maria Lia Palomba
    165 Palomba